Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Coleman

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2021
Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such TreatmentT A Ige, A Jenkins, G Burt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
RTOG #89-06: a phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignanciesF E Halberg, D Cosmatis, L L Gunderson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvementL Hughes-Davies, N J Tarbell, C N Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trialP M Mauch, G P Canellos, L N Shulman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1987
Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's diseaseJ Watchie, C N Coleman, T A Raffin, et al.
Cancer|June 15, 1994
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomasP Y Wen, E Alexander, P M Black, et al.
Cancer|January 28, 1998
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliterA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTVA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Initial pharmacology and toxicology of intravenous desmethylmisonidazoleC N Coleman, T H Wasserman, T L Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Distribution of etanidazole into human brain tumors: implications for treating high grade gliomasS J Hurwitz, C N Coleman, N Riese, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2021
Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such TreatmentT A Ige, A Jenkins, G Burt, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1994
RTOG #89-06: a phase I study to evaluate intraoperative radiation therapy and the hypoxic cell sensitizer etanidazole in locally advanced malignanciesF E Halberg, D Cosmatis, L L Gunderson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvementL Hughes-Davies, N J Tarbell, C N Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trialP M Mauch, G P Canellos, L N Shulman, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1987
Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's diseaseJ Watchie, C N Coleman, T A Raffin, et al.
Cancer|June 15, 1994
Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomasP Y Wen, E Alexander, P M Black, et al.
Cancer|January 28, 1998
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliterA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 1997
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTVA V D'Amico, R Whittington, I Kaplan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Initial pharmacology and toxicology of intravenous desmethylmisonidazoleC N Coleman, T H Wasserman, T L Phillips, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Distribution of etanidazole into human brain tumors: implications for treating high grade gliomasS J Hurwitz, C N Coleman, N Riese, et al.
Pageof 14